BRIEF-Gilead Sciences says European CHMP adopts positive opinion for its drug

* European chmp adopts positive opinion for gilead's taf-based single tablet regimen odefsey (emtricitabine, rilpivirine, tenofovir alafenamide) for treatment of hiv Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)